Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Obesity is in epidemic proportions in many parts of the world, contributing to increasing rates of non-alcoholic fatty liver disease (NAFLD). NAFLD represents a range of conditions from the initial stage of fatty liver to non-alcoholic steatohepatitis (NASH), which can progress to severe fibrosis, t...

Full description

Bibliographic Details

Published in:	Antioxidants
Main Authors:	Tharani Senavirathna, Armaghan Shafaei, Ricky Lareu, Lois Balmer
Format:	Article
Language:	English
Published:	MDPI AG 2024-04-01
Subjects:	ellagic acid urolithins non-alcoholic fatty liver disease non-alcoholic steatohepatitis dietarily interventions
Online Access:	https://www.mdpi.com/2076-3921/13/4/485